Lexaria Bioscience Corp.
General ticker "LEXX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $22.4M (TTM average)
Lexaria Bioscience Corp. does not follow the US Stock Market performance with the rate: -11.8%.
Estimated limits based on current volatility of 4.3%: low 1.04$, high 1.14$
Factors to consider:
- Total employees count: 7 (+40.0%) as of 2024
- Top business risk factors: Product commercialization failure, Labor/talent shortage/retention, Market competition, Cybersecurity threats, Intellectual property risks
- Current price 14.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-08-31 to 2026-08-31
- 2024-08-31 to 2025-08-31 estimated range: [1.82$, 4.82$]
- 2025-08-31 to 2026-08-31 estimated range: [1.32$, 3.70$]
Financial Metrics affecting the LEXX estimates:
- Positive: with PPE of -6.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.67 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 90.62 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -20.63 <= 0
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.48 > -0.66
Short-term LEXX quotes
Long-term LEXX plot with estimates
Financial data
| YTD | 2022-08-31 | 2023-08-31 | 2024-08-31 |
|---|---|---|---|
| Operating Revenue | $0.26MM | $0.23MM | $0.46MM |
| Operating Expenses | $6.87MM | $6.76MM | $6.22MM |
| Operating Income | $-6.62MM | $-6.53MM | $-5.75MM |
| Non-Operating Income | $-0.76MM | $-0.18MM | $-0.06MM |
| R&D Expense | $1.84MM | $3.67MM | $2.36MM |
| Income(Loss) | $-7.38MM | $-6.71MM | $-5.81MM |
| Profit(Loss)* | $-7.27MM | $-6.66MM | $-5.80MM |
| Stockholders Equity | $7.95MM | $3.04MM | $8.04MM |
| Inventory | $0.04MM | $0.00MM | $0.00MM |
| Assets | $7.83MM | $3.08MM | $8.87MM |
| Operating Cash Flow | $-4.88MM | $-5.88MM | $-4.96MM |
| Capital expenditure | $0.13MM | $0.17MM | $0.04MM |
| Investing Cash Flow | $-0.18MM | $-0.17MM | $-0.19MM |
| Financing Cash Flow | $-0.04MM | $1.59MM | $10.30MM |
| Earnings Per Share** | $-1.24 | $-1.01 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.